The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
12/20/2022 | Rob Coker | 4 min read
For any organization, one ill-timed tweet can create enormous backlash.
12/13/2022 | Angus Stewart
In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?
12/09/2022 | Angus Stewart | 10 min read
Sitting Down With… Gen Li, CEO, Phesi
12/08/2022 | Angus Stewart | 3 min read
A year of turmoil, and a year of change – just how healthy are pharma and the life sciences?
11/29/2022 | Angus Stewart | 9 min read
After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?
11/29/2022 | Avi Kulkarni | 3 min read
Can AI realistically transform data management in pharma? Yes. And it’s already begun.
11/20/2022 | Angus Stewart | 4 min read
What did switching from client to constructor teach a seasoned biotech professional?
11/14/2022 | Stephanie Sutton | 2 min read
Fake tweet announcing free insulin leads to mayhem.
11/09/2022 | Stephanie Sutton | 2 min read
How a new working group plans to overcome the problem with in vitro pharmacology data.
11/08/2022 | Stephanie Sutton | 2 min read
Unregulated drugs being sold and distributed by the online retailer come under fire.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
The Grand Winner
How Data Sharing Can Upgrade AI for Pharma
Welcome to the CRISPR Powerhouse